BRCA1 and BRCA2 testing: weighing the demand against the benefits.
Devilee
P
P
D000328:Adult; D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics; D005192:Family Health; D005260:Female; D018703:Founder Effect; D005787:Gene Frequency; D019398:Genes, BRCA1 / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing / Q000191:economics; D006801:Humans; D007055:Iceland; D007585:Jews / Q000235:genetics; D008126:Lod Score; D009363:Neoplasm Proteins / Q000235:genetics*; D010051:Ovarian Neoplasms / Q000453:epidemiology / Q000235:genetics; D015995:Prevalence; D018570:Risk Assessment / Q000706:statistics & numerical data; D014157:Transcription Factors / Q000235:genetics*
D024682:BRCA2 Protein; D009363:Neoplasm Proteins; D014157:Transcription Factors